Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients
- 3 October 2016
- journal article
- case report
- Published by BMJ in BMJ Case Reports
- Vol. 2016
Abstract
This case report series describes 3 cases of cisatracurium besylate associated phlebitis after an infusion period of 14–20 hours. No similar cases have been reported in the literature. Association of phlebitis with another neuromuscular blocking agent, atracurium, has been described in the literature. The acidity of atracurium is thought to be the main cause. It is recommended that atracurium is administered only via central venous catheters when indicated to infuse over prolonged periods of time due to the acidity. Cisatracurium is a stereoisomer of atracurium and as such has the same molecular weight. Although cisatracurium also has a similar acidity as atracurium, a recommendation concerning infusion via a central venous catheter is lacking. We suggest prolonged administration of cisatracurium besylate only via centrally placed venous catheters or if not possible to careful monitor relevant peripheral intravenous sites to diminish the risks of phlebitis and associated complications or other cutaneous reactions.Keywords
This publication has 11 references indexed in Scilit:
- Clinically-indicated replacement versus routine replacement of peripheral venous cathetersCochrane Database of Systematic Reviews, 2015
- Use of cisatracurium in critical care: a review of the literature.2014
- Pharmacodynamics of cisatracurium in the intensive care unit: an observational studyAnnals of Intensive Care, 2014
- Current Therapeutic Uses, Pharmacology, and Clinical Considerations of Neuromuscular Blocking Agents for Critically III AdultsAnnals of Pharmacotherapy, 2011
- Neuromuscular Blockers in Early Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2010
- Should In-line Filters Be Used in Peripheral Intravenous Catheters to Prevent Infusion-Related Phlebitis? A Systematic Review of Randomized Controlled TrialsAnesthesia & Analgesia, 2010
- Peripheral intravenous catheter-related phlebitis and related risk factors.2007
- A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patientsIntensive Care Medicine, 2002
- Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cellsNutrition, 1998
- Atracurium Infusion in the Intensive Care UnitBritish Journal of Anaesthesia, 1986